Literature DB >> 20848161

Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia.

M Kuoppala1, J Åkeson, P Svensson, B Lindblad, S Franzen, S Acosta.   

Abstract

Assessment of clinical risk factors for haemorrhagic complications in patients undergoing intra-arterial thrombolysis for lower limb ischaemia. Retrospective reviews of consecutive patients subjected to intra-arterial thrombolysis due to lower limb ischemia at the Vascular Center, Malmö University Hospital, during a 5-year period from 2001 to 2005. Two hundred and twenty intra-arterial thrombolytic procedures were carried out in 195 patients (46% women), median age 73 years. Haemorrhagic complications were recorded in 72 procedures (33%), of which 13 were discontinued. Haemorrhage at the introducer and distant sites occurred in 53 and 32 procedures, respectively. Thrombolysis for occluded synthetic grafts was associated with higher risk of haemorrhage (P = 0.043). The platelet count was lower (P = 0.017) and the dose of alteplas higher (P = 0.041) in bleeders than in non-bleeders. Age was not associated with haemorrhage (P = 0.30). Two patients died during thrombolysis, one of them due to intracerebral haemorrhage. The grade of thrombolysis was an independent predictor of both in-hospital amputation (P < 0.001; OR 3.5 [95% CI 2.1-5.8]) and mortality (P = 0.021; OR 3.0 [95% CI 1.2-7.9]). The in-hospital amputation-free survival rate was 85% (188/220). Haemorrhage associated with thrombolysis is common, but does seldom require discontinuation of treatment. Insertion of introducers for local thrombolysis through synthetic grafts, lower platelet count and higher alteplas dose were found to be risk factors for haemorrhage. An algorithm for clinical management of haemorrhage has been proposed.

Entities:  

Mesh:

Year:  2011        PMID: 20848161     DOI: 10.1007/s11239-010-0520-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  21 in total

Review 1.  Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section C: acute limb ischaemia.

Authors: 
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-06       Impact factor: 7.069

2.  Failure of thrombolytic therapy to improve long-term vascular patency.

Authors:  G L Faggioli; R M Peer; L Pedrini; M D Di Paola; J A Upson; M D'Addato; J J Ricotta
Journal:  J Vasc Surg       Date:  1994-02       Impact factor: 4.268

3.  Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications.

Authors:  J L Swischuk; P F Fox; K Young; S Hussain; B Smouse; F Castañeda; T M Brady
Journal:  J Vasc Interv Radiol       Date:  2001-04       Impact factor: 3.464

4.  Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.

Authors: 
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

5.  Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Michael Sobel; Raymond Verhaeghe
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 6.  Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.

Authors:  Cindy A Leissinger; Philip M Blatt; W Keith Hoots; Bruce Ewenstein
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

7.  Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

Authors:  J H Gurwitz; J M Gore; R J Goldberg; H V Barron; T Breen; A C Rundle; M A Sloan; W French; W J Rogers
Journal:  Ann Intern Med       Date:  1998-10-15       Impact factor: 25.391

8.  Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

Authors:  J M Gore; C B Granger; M L Simoons; M A Sloan; W D Weaver; H D White; G I Barbash; F Van de Werf; P E Aylward; E J Topol
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

9.  Long-term prognostic factors after thrombolysis for lower limb ischemia.

Authors:  Monica Kuoppala; Sofia Franzén; Bengt Lindblad; Stefan Acosta
Journal:  J Vasc Surg       Date:  2008-06       Impact factor: 4.268

10.  Prognostic value of preoperative C-reactive protein concentration and white cell count in acute extremity ischaemia.

Authors:  P Kuukasjärvi; J P Salenius; H Riekkinen
Journal:  Eur J Surg       Date:  1995-05
View more
  5 in total

1.  Dose-Response Relationship and Threshold Drug Dosage Identification for a Novel Hybrid Mechanical-Thrombolytic System with an Ultra-Low Dose Patch.

Authors:  Zhen Qin; Chi Hang Chon; John Ching Kwong Kwok; Peter Yat Ming Woo; David C C Lam
Journal:  Cell Mol Bioeng       Date:  2021-06-10       Impact factor: 3.337

Review 2.  Acute Limb Ischemia: An Update on Diagnosis and Management.

Authors:  Dan-Mircea Olinic; Agata Stanek; Dan-Alexandru Tătaru; Călin Homorodean; Maria Olinic
Journal:  J Clin Med       Date:  2019-08-14       Impact factor: 4.241

3.  Mechanically assisted intra-arterial thrombolysis in acute cerebral infarction.

Authors:  Hui-Xiao Wang; Yi-Jin Shen; Shu-Jun Ye; Yong-Kang Xu; Jian-Pin Zhang; Zhou Lu
Journal:  Exp Ther Med       Date:  2013-03-06       Impact factor: 2.447

4.  Percutaneous mechanical thrombectomy of superior mesenteric artery embolism.

Authors:  Dimitrij Kuhelj; Pavel Kavcic; Peter Popovic
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

5.  Outcome and complications after intra-arterial thrombolysis for lower limb ischaemia with or without continuous heparin infusion.

Authors:  O Grip; M Kuoppala; S Acosta; A Wanhainen; J Åkeson; M Björck
Journal:  Br J Surg       Date:  2014-06-25       Impact factor: 6.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.